Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) shares dropped 5.1% during mid-day trading on Monday . The stock traded as low as $21.00 and last traded at $21.71. Approximately 41,175 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 154,192 shares. The stock had previously closed at $22.87.
Wall Street Analysts Forecast Growth
Separately, Truist Financial raised their target price on shares of Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, April 11th.
Check Out Our Latest Report on Guardian Pharmacy Services
Guardian Pharmacy Services Stock Performance
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services during the 4th quarter worth $30,000. Investment Research & Advisory Group Inc. acquired a new position in Guardian Pharmacy Services during the fourth quarter worth about $34,000. BNP Paribas Financial Markets purchased a new position in Guardian Pharmacy Services in the fourth quarter valued at about $37,000. Compass Financial Services Inc purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth approximately $58,000. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth approximately $77,000.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
- Five stocks we like better than Guardian Pharmacy Services
- Profitably Trade Stocks at 52-Week Highs
- Lemonade: Leveraging AI to Underwrite a Path to Profitability
- What Investors Need to Know About Upcoming IPOs
- 2 Penny Stocks With $10 Potential
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Why Uber’s Stock Could Soar on AV Growth and Tariff Resilience
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
